Abstract:Tumours do not exist in isolation from the organism; their growth, proliferation, motility, and immunosuppressive response are intricately connected to the tumour's microenvironment. As tumour cells and the microenvironment coevolve, an inflammatory microenvironment ensues, propelling the phenomenon of inflammation-cancer transformation-an idea proposed by modern medicine. This review aims to encapsulate the array of representative factors within the tumour's inflammatory microenvironment, such as interleukins (IL-6, IL-10, IL-17, IL-1β), transforming growth factor-beta (TGF-β), interferon-gamma (IFN-γ), tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMPs). Moreover, drawing upon research in traditional Chinese medicine (TCM) and pharmacology, we explore the delicate interplay between these factors and tumour-associated inflammatory cells: tumour-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), tumour-associated neutrophils (TANs) and dendritic cells (DCs). By analyzing the tumour-promoting effects of these entities, we delve into the connotations of Academician Tong Xiao-lin's novel model of "state-target differentiation" and its application in the diagnosis and treatment of tumours. Our aim is to enhance the precision and targeting of tumour treatment in clinical practice. Delving deeper into our understanding of tumour pathogenesis through the lens of modern medicine, we discern the key etiology and pathogenesis throughout the entire developmental stage of tumours, unveiling the evolutionary patterns of Chinese Medicine (CM) states: heat state → phlegm state → stagnation state → deficiency state. Building upon this foundation, we devised a state-regulating formula. Simultaneously, drawing on pharmacological research in traditional Chinese medicine (TCM), we meticulously identified a range of targeted drugs that effectively modulate the aforementioned tumour-related mediators. This comprehensive strategy-a harmonious integration of state identification, target recognition, and simultaneous regulation-aims to elevate clinical efficacy. The fusion of TCM with Western medicine in tumour treatment introduces novel dimensions to the precise and refined application of TCM in clinical practice.

Research Progress of Traditional Chinese Medicine Therapy of Malignant Tumors Cancerous Cachexia

Cancer cachexia：pathogenic mechanisms and therapeutic perspectives

Understanding cachexia and its impact on lung cancer and beyond

The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world

Exploring the Potential Use of Chinese Herbs in Regulating the Inflammatory Microenvironment of Tumours Based on the Concept of ‘State-Target Identification and Treatment’: a Scooping Review

Targeting cancer cachexia: Molecular mechanisms and clinical study

Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment

Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: Progress, challenges and reflections

Metabolomics‐driven discovery of therapeutic targets for cancer cachexia

Molecular mechanisms of cancer cachexia‐induced muscle atrophy (Review)

Efficacy and safety of herbal medicines intervention for cachexia associated with cancer: A systematic review and meta‐analysis

Efficacy of traditional Chinese medicine in treating cancer

The Effectiveness of Traditional Chinese Medicine in Treating Malignancies via Regulatory Cell Death Pathways and the Tumor Immune Microenvironment: A Review of Recent Advances

Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms

The Management of Cancer Cachexin: Drug and Nutrition

Recent Highlights of Experimental Research for Inhibiting Tumor Growth by Using Chinese Medicine

Molecular Mechanisms of Cachexia: A Review

Exosomes in the pathogenesis and treatment of cancer-related cachexia

Research advances of traditional Chinese medicine in cancer immunotherapy

Investigation of traditional Chinese medicine for cancer treatment: Signaling pathways and anti-tumor microenvironment

The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases